Digital pathology
Paige
Digital pathology AI applications for cancer pathology, including Paige Prostate.
Last updated: June 5, 2026
Back to directoryAignostics medical AI product profile
Digital pathology AI company whose Atlas H&E-TME product analyzes whole-slide images for tumor microenvironment profiling in research workflows.
Digital pathology
Best fit
Research and biopharma teams that need quantitative H&E tumor microenvironment features, validation documentation, and controlled data-handling terms.
- Primary use case
- Research-use digital pathology foundation-model analysis for H&E tumor microenvironment profiling and quantitative spatial metrics
- Audience
- Biopharma translational research teams, digital pathology researchers, academic groups, and biomarker discovery teams
- Risk level
- High
- Pricing signal
- Research access, biopharma, and partner pricing; request current terms.
- Official sources
- 3 official sources
Compare within workflow: Digital pathology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Aignostics as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat Atlas H&E-TME as research-use pathology AI unless Aignostics provides product-specific diagnostic authorization for the intended workflow. |
|---|---|
| Privacy | Verify customer-contract data handling, GDPR scope, ISO 27001 controls, processing location, retention, deletion, and slide-identification handling before upload. |
| Evidence | Review the validation benchmark for each cancer type, tissue segment, cell class, scanner/stain context, and quantitative endpoint used in the research protocol. |
| Workflow | Keep outputs in translational research, biomarker discovery, or study-analysis workflows with scientific review rather than clinical reporting. |
Where Aignostics fits
Aignostics describes Atlas H&E-TME as a research-use tumor microenvironment profiling product powered by a histopathology foundation model, with broad cancer coverage, quantitative metrics, validation documents, GDPR and ISO 27001 statements, and an explicit not-for-diagnostic-use limitation.
Not for: Clinical diagnostic use, pathologist signout, treatment selection, or deployment as a regulated diagnostic procedure.
What to verify before using Aignostics
- Research-use-only status and whether any workflow is explicitly excluded from diagnostic procedures.
- Supported cancer types, tissue types, sample types, slide-quality controls, and model-validation benchmarks.
- How uploaded slides are processed, protected in transit, retained, deleted, and contractually restricted.
- Whether quantitative outputs, cell classes, tissue regions, QC flags, and spatial metrics are reproducible enough for the study protocol.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.aignostics.com / products / atlas-he-tme
- www.aignostics.com
- www.aignostics.com / company / about
Related medical AI products
Digital pathology
PathAI
AI-enabled digital pathology platform with image management and algorithm access.
Digital pathology
Hologic Genius Digital Diagnostics
FDA-cleared digital cytology system combining volumetric imaging, Genius Cervical AI, image management, and cytologist or pathologist review.
Digital pathology
Ibex Medical Analytics
Clinical-grade AI pathology platform for cancer diagnostics and pathology workflow support.